Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
13.9 to 15.4% A1c reduction over tirzepatide arms Manufacturer / Eli Lilly and Company Schedule / not a controlled substance Biosimilar status / no approved biosimilars as of January 2025 Postmarket requirement / 10-year medullary thyroid carcinoma registry ongoing What Is Mounjaro and How Did It Reach FDA Review
During the first 812 weeks, calorie reduction is dramatic due to appetite suppression
Presented for research literature review only Dubelaar ML et al
So we tend to shy away from doing elective cosmetic procedures on patients whose BMI is over 35
US$ 27.03
US$ 24.23
US$ 29.51
US$ 22.72
